Two-Thirds of Mylan Shareholders Support Acquisition of Perrigo September 3, 2015 Mylan plans to offer $75 and 2.3 ordinary shares of stock for each Perrigo ordinary share. Read More
CeQur Announces $100 Million in Financing for Insulin Infusion Device September 2, 2015 The financing will support clinical and regulatory activities, manufacturing scale-up and commercial operations. Read More
Federal Judge Allows AbbVie, Teva to Continue Delay of Testosterone Drug Launch September 2, 2015 The judge rejected the FTC’s request to reconsider the pay-for-delay charges. Read More
Medtronic Acquires Medina for $150 Million September 1, 2015 Medina develops treatments for vascular abnormalities of the brain, including the Medina embolization device to treat brain aneurysms. Read More
PTAB Agrees to Review Mylan Challenge to Teva Patents September 1, 2015 The inter partes review indicates a reasonable likelihood that Mylan will prevail. Read More
French Hospital Becomes the First to Treat Patients With Leksell Gamma Knife Icon August 31, 2015 The system was used to treat a metastasis in the brain of a 71-year-old female patient. Read More
Medivation to Acquire BioMarin’s Breast Cancer Drug Talazoparib August 31, 2015 Medivation will pay $410 million upfront and up to $160 million for regulatory and sales-based milestones. Read More
Greatbatch Acquires Lake Region Medical, Partners With WiTricity August 28, 2015 The deals give Greatbatch access to Lake Region Medical's device portfolio and Witricity’s wireless charging technology. Read More
Exelixis’ Cancer Drug Receives FDA Breakthrough Therapy Designation August 28, 2015 The designation is based on results of a Phase 3 trial showing cabozantinib reduced disease progression or death by 42 percent. Read More
Rivanna Begins Manufacturing of Accuro Device August 27, 2015 The device is designed to guide spinal anesthesia with automated 3D navigation technology. Read More
Drugmakers Ask Appeals Court to Review Ruling on Biosimilar Approval August 27, 2015 Sandoz and Amgen say the ruling is contrary to Congress’ intent in the Biologics Price Competition and Innovation Act. Read More
Medtronic Acquires Twelve for $458 Million August 26, 2015 Twelve’s transcatheter mitral valve replacement device is designed to treat mitral valve regurgitation in patients. Read More